Nifty

:

22620.40

Sensex

:

73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Login

Nifty
Sensex

:
:

22620.40
73730.16

50.05 (0.22%)
-609.28 (-0.82%)

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

Rating :

33/99

BSE: 539872 | NSE: BAJAJHCARE

Watchlist

NSE BSE

327.35

26-Apr-2024

Open
High
Low
Previous Close

330.95
331.45
325.55
328.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

37230
122.15
513.40
275.70

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

909.37
42.76
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,255.14
0.30%
2.83

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.75
15.68
0.82

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.51
20.03
-4.74

PAT CAGR (%)

10 Years
5 Years
3 Years

35.25
21.41
-19.71

P:E (Median)

8 Years
5 Years
3 Years

17.83
15.97
15.54

P:BV (Average)

8 Years
5 Years
3 Years

3.40
3.40
3.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.61
9.91
10.77

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 108.57 132.57 -18.10% 101.21 195.32 -48.18% 129.74 163.79 -20.79% 158.44 175.71 -9.83%
Expenses 89.04 102.14 -12.83% 82.26 160.88 -48.87% 107.99 139.32 -22.49% 139.38 150.51 -7.39%
EBITDA 19.54 30.43 -35.79% 18.95 34.44 -44.98% 21.74 24.47 -11.16% 19.06 25.21 -24.40%
EBIDTM 17.99% 22.96% 18.72% 17.63% 16.76% 14.94% 12.03% 14.35%
Other Income 0.80 0.07 1,042.86% 1.22 0.13 838.46% 0.22 0.67 -67.16% 0.72 0.45 60.00%
Interest 6.65 5.37 23.84% 8.26 3.64 126.92% 8.75 2.58 239.15% 7.36 4.49 63.92%
Depreciation 7.35 4.43 65.91% 6.66 4.00 66.50% 6.31 4.08 54.66% 7.42 4.24 75.00%
PBT 6.33 20.71 -69.44% 5.24 26.92 -80.53% 6.90 18.47 -62.64% 5.00 16.93 -70.47%
Tax 0.80 3.96 -79.80% 0.12 5.64 -97.87% -0.12 4.12 - 1.41 -0.54 -
PAT 5.52 16.75 -67.04% 5.12 21.28 -75.94% 7.03 14.35 -51.01% 3.59 17.47 -79.45%
PATM 5.09% 12.63% 5.06% 10.89% 5.42% 8.76% 2.27% 9.94%
EPS 2.00 6.07 -67.05% 1.86 7.71 -75.88% 2.55 5.20 -50.96% 1.30 6.33 -79.46%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 497.96 673.29 679.89 656.98 410.01 325.02 289.51 207.24 200.23 197.25 185.71 Net Sales Growth -25.39% -0.97% 3.49% 60.24% 26.15% 12.27% 39.70% 3.50% 1.51% 6.21% Cost Of Goods Sold 287.50 398.64 406.14 377.89 263.23 196.87 177.68 111.23 105.65 110.94 113.25 Gross Profit 210.46 274.65 273.75 279.09 146.78 128.15 111.83 96.01 94.57 86.31 72.46 GP Margin 42.26% 40.79% 40.26% 42.48% 35.80% 39.43% 38.63% 46.33% 47.23% 43.76% 39.02% Total Expenditure 418.67 566.33 561.23 520.62 361.73 282.09 250.08 176.40 170.18 168.43 166.14 Power & Fuel Cost - 41.46 31.83 24.96 24.24 21.83 19.81 16.79 14.12 13.42 11.22 % Of Sales - 6.16% 4.68% 3.80% 5.91% 6.72% 6.84% 8.10% 7.05% 6.80% 6.04% Employee Cost - 47.84 41.11 34.55 28.18 24.62 21.65 19.57 16.93 14.45 12.06 % Of Sales - 7.11% 6.05% 5.26% 6.87% 7.57% 7.48% 9.44% 8.46% 7.33% 6.49% Manufacturing Exp. - 51.49 59.68 64.02 28.56 25.07 21.53 19.89 23.16 22.73 21.30 % Of Sales - 7.65% 8.78% 9.74% 6.97% 7.71% 7.44% 9.60% 11.57% 11.52% 11.47% General & Admin Exp. - 13.68 12.74 11.03 7.95 6.64 5.06 5.76 5.87 5.03 5.22 % Of Sales - 2.03% 1.87% 1.68% 1.94% 2.04% 1.75% 2.78% 2.93% 2.55% 2.81% Selling & Distn. Exp. - 3.80 3.91 4.17 1.28 1.77 1.64 1.26 1.17 1.24 1.10 % Of Sales - 0.56% 0.58% 0.63% 0.31% 0.54% 0.57% 0.61% 0.58% 0.63% 0.59% Miscellaneous Exp. - 9.42 5.81 4.00 8.28 5.29 2.70 1.90 3.28 0.62 1.10 % Of Sales - 1.40% 0.85% 0.61% 2.02% 1.63% 0.93% 0.92% 1.64% 0.31% 1.07% EBITDA 79.29 106.96 118.66 136.36 48.28 42.93 39.43 30.84 30.05 28.82 19.57 EBITDA Margin 15.92% 15.89% 17.45% 20.76% 11.78% 13.21% 13.62% 14.88% 15.01% 14.61% 10.54% Other Income 2.96 1.60 1.44 6.91 6.53 0.97 2.07 2.39 0.38 0.07 0.10 Interest 31.02 22.99 12.78 8.34 6.63 8.32 7.73 8.20 7.64 8.02 7.43 Depreciation 27.74 27.35 17.64 16.12 12.12 11.41 11.08 11.35 9.29 8.86 8.95 PBT 23.47 58.22 89.68 118.82 36.06 24.17 22.68 13.69 13.50 12.02 3.29 Tax 2.21 15.19 18.30 35.71 10.82 7.86 7.50 5.87 5.30 4.50 1.19 Tax Rate 9.42% 26.09% 20.41% 30.05% 30.01% 32.52% 33.07% 42.88% 39.26% 37.44% 36.17% PAT 21.26 43.02 71.39 83.11 25.24 16.31 15.19 7.82 8.20 7.51 2.10 PAT before Minority Interest 21.26 43.02 71.39 83.11 25.24 16.31 15.19 7.82 8.20 7.51 2.10 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.27% 6.39% 10.50% 12.65% 6.16% 5.02% 5.25% 3.77% 4.10% 3.81% 1.13% PAT Growth -69.56% -39.74% -14.10% 229.28% 54.75% 7.37% 94.25% -4.63% 9.19% 257.62% EPS 7.70 15.59 25.87 30.11 9.14 5.91 5.50 2.83 2.97 2.72 0.76

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 367.69 328.49 258.41 177.93 129.11 113.61 99.00 88.63 81.93 31.30 Share Capital 13.80 13.80 13.80 13.80 6.90 6.90 6.90 6.75 3.75 3.75 Total Reserves 353.89 314.69 244.61 164.13 122.21 106.71 92.10 81.88 78.18 27.55 Non-Current Liabilities 97.71 70.54 84.65 27.40 20.41 23.45 27.69 32.26 22.24 14.26 Secured Loans 93.66 66.31 79.71 22.97 16.19 19.80 24.41 27.45 17.55 8.98 Unsecured Loans 0.00 0.00 0.00 0.60 1.20 1.68 2.43 4.00 4.67 5.57 Long Term Provisions 2.79 2.67 2.78 2.08 1.42 0.77 0.00 0.00 0.00 0.00 Current Liabilities 436.06 322.07 182.57 137.61 117.34 131.07 92.55 88.13 84.54 99.31 Trade Payables 84.75 104.92 68.95 57.48 29.98 43.38 18.85 16.17 22.75 30.61 Other Current Liabilities 47.55 31.44 24.98 21.18 25.62 25.93 20.02 20.06 18.91 18.89 Short Term Borrowings 289.42 176.20 88.47 58.43 54.89 54.52 39.16 42.29 37.42 48.57 Short Term Provisions 14.34 9.51 0.18 0.52 6.84 7.25 14.52 9.60 5.45 1.25 Total Liabilities 901.46 721.10 525.63 342.94 266.86 268.13 219.24 209.02 188.71 144.87 Net Block 365.69 269.74 208.13 162.24 128.50 126.62 127.93 129.56 108.50 55.88 Gross Block 525.01 401.73 329.25 267.83 222.23 209.65 199.88 191.39 161.81 100.48 Accumulated Depreciation 159.32 131.99 121.13 105.59 93.74 83.03 71.95 61.83 53.31 44.60 Non Current Assets 391.72 322.79 267.30 174.53 129.68 128.59 128.16 131.02 109.68 58.65 Capital Work in Progress 21.73 51.98 57.05 5.45 1.18 1.97 0.23 1.46 1.17 2.77 Non Current Investment 0.00 0.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 4.30 1.07 2.12 1.84 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 509.74 398.31 258.33 168.42 137.17 139.55 91.08 78.00 79.03 86.23 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 208.79 159.26 97.11 39.28 30.05 33.66 16.76 19.64 18.08 23.20 Sundry Debtors 227.41 184.51 98.88 98.48 78.13 80.38 52.69 42.95 51.52 54.76 Cash & Bank 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 0.99 Other Current Assets 55.83 37.59 32.00 13.37 21.13 17.21 20.79 15.04 8.56 7.27 Short Term Loans & Adv. 14.23 14.97 16.10 13.13 18.79 14.98 18.19 12.84 6.73 5.03 Net Current Assets 73.68 76.24 75.76 30.80 19.83 8.47 -1.47 -10.13 -5.51 -13.09 Total Assets 901.46 721.10 525.63 342.95 266.85 268.14 219.24 209.02 188.71 144.88

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -22.32 0.69 43.56 20.57 25.17 16.61 22.12 25.14 27.89 17.32 PBT 58.22 89.68 118.82 36.06 24.17 22.68 13.69 13.50 12.02 3.29 Adjustment 55.89 31.47 24.48 15.54 20.06 18.77 19.32 16.83 16.70 16.06 Changes in Working Capital -124.89 -110.84 -64.09 -21.91 -6.04 -18.88 -5.81 -0.31 -0.08 -1.76 Cash after chg. in Working capital -10.79 10.32 79.21 29.70 38.19 22.58 27.20 30.03 28.63 17.59 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.54 -9.63 -35.65 -9.12 -13.02 -5.96 -5.08 -4.89 -0.74 -0.27 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -93.43 -74.80 -108.93 -27.56 -13.03 -11.64 -8.45 -30.67 -16.71 -8.72 Net Fixed Assets -93.03 -67.41 -113.02 -49.87 -11.79 -11.51 -7.26 -29.87 -59.73 -8.80 Net Investments 0.00 0.00 5.00 -5.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -0.40 -7.39 -0.91 27.31 -1.24 -0.13 -1.19 -0.80 43.02 0.08 Cash from Financing Activity 131.50 61.85 75.46 3.28 -12.57 2.47 -13.20 5.08 -11.36 -7.74 Net Cash Inflow / Outflow 15.75 -12.27 10.08 -3.70 -0.42 7.45 0.47 -0.44 -0.18 0.86 Opening Cash & Equivalents 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 0.99 0.13 Closing Cash & Equivalent 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.42 0.81 0.99

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 133.23 119.02 93.63 64.47 64.41 52.73 71.74 34.33 27.64 22.08 ROA 5.30% 11.45% 19.14% 8.28% 6.10% 6.23% 3.65% 4.12% 4.50% 1.53% ROE 12.36% 24.33% 38.09% 18.92% 20.18% 17.68% 10.77% 19.60% 22.38% 7.31% ROCE 11.88% 20.00% 35.91% 19.47% 19.75% 18.25% 14.52% 18.00% 19.16% 10.67% Fixed Asset Turnover 1.45 1.86 2.20 1.67 1.71 1.60 1.18 1.26 1.66 2.15 Receivable days 111.65 76.07 54.82 78.61 78.15 74.24 75.67 77.37 88.85 88.49 Inventory Days 99.76 68.82 37.89 30.86 31.41 28.13 28.80 30.89 34.51 35.14 Payable days 86.83 78.13 61.06 43.87 46.86 44.67 35.97 41.39 56.94 53.59 Cash Conversion Cycle 124.58 66.76 31.65 65.59 62.70 57.71 68.50 66.87 66.43 70.03 Total Debt/Equity 1.13 0.78 0.70 0.51 0.91 1.19 0.76 1.75 1.77 2.25 Interest Cover 3.53 8.02 15.25 6.44 3.91 3.93 2.67 2.77 2.50 1.44

Top Investors:

maa sharda distributors private limited

vls finance ltd

Annual Reports:

News Update:

Bajaj Healthcare enters into definitive CDMO agreement with UK/EU based customers
28th Feb 2024, 13:00 PM

BHL will undertake the development and supply of these molecules, which will be exclusively manufactured for its clientele
Read More
Bajaj Healthcare - Quarterly Results
9th Feb 2024, 20:07 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback